Si-Bone (SIBN) Capital Expenditures Growth (3y) (2020 - 2026)
Si-Bone (SIBN) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 2.15% |
| 10 | Si-Bone | 753.47 Mn | 608.79 Mn | 41.94 Mn | -41.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.17% |
| Dec 31, 2025 | 0.50% |
| Sep 30, 2025 | 19.59% |
| Jun 30, 2025 | -36.21% |
| Mar 31, 2025 | -3.05% |
| Dec 31, 2024 | 15.24% |
| Sep 30, 2024 | -0.30% |
| Jun 30, 2024 | 21.44% |
| Mar 31, 2024 | -14.66% |
| Dec 31, 2023 | 10.19% |
| Sep 30, 2023 | 57.07% |
| Jun 30, 2023 | -189.44% |
| Mar 31, 2023 | 267.41% |
| Dec 31, 2022 | -68.55% |
| Sep 30, 2022 | 83.15% |
| Jun 30, 2022 | 60.83% |
| Mar 31, 2022 | 76.72% |
| Dec 31, 2021 | 86.83% |
| Sep 30, 2021 | -291.38% |
| Jun 30, 2021 | 172.82% |